New Study Suggests ECG-AI can Detect Cardiovascular Disease Risks Sooner

Artificial intelligence (AI) from patient electrocardiograms (ECGs) may be an innovative solution to enhance heart disease risk assessment. Atherosclerotic cardiovascular disease - arteries narrowed or blocked by the accumulation of fatty plaques - is the leading global cause of death and is often driven by coronary artery disease. New study data published in eClinicalMedicine suggest that ECG-AI can flag some risks years sooner than current risk calculator equations by identifying signs of coronary artery disease, such as calcification and blockages, as well as evidence of a prior heart attack.

Many people may have coronary artery disease and not be aware of it. Unfortunately, the first sign of the disease could be sudden death or a major heart attack. Clinician tools, such as the pooled cohort equation, help determine a patient's 10-year risk for heart attacks and strokes. The tools guide shared decisions about the timing of therapies, but these tools have limitations.

ECG is a widely available test that measures the heart's electrical activity, and AI can be trained to identify and detect hidden patterns of disease from those electrical signals.

The ECG-AI to predict coronary artery disease was developed at Mayo Clinic and Anumana using the retrospective analysis of electronic health data of over 7 million patients across the U.S. Three separate ECG-AI models were trained, one each to detect coronary artery calcium, coronary artery blockage and segments of the heart's left ventricle not moving well - a sign of a prior heart attack.

"Used together, the three independent ECG-AI models predicted which patients had a high risk of hidden coronary artery disease, and therefore a high risk of having a heart attack. This is important information to guide our conversations with patients at the point of care, especially since the AI was useful in calculating these risks for as short as three years," says Francisco Lopez-Jimenez, M.D., a cardiologist at Mayo Clinic and senior author of the paper. "Used alone, the pooled cohort equation estimates the 10-year risk of developing cardiovascular disease. The addition of ECG-AI to see hidden risks sooner has the potential to save more lives. This model may also help identify people who do not know they have coronary disease who may benefit from lifesaving therapies."

The study was funded by Anumana, a spinoff company of nference and Mayo Clinic. Mayo Clinic has licensed this technology to Anumana. Mayo Clinic and authors of this study may benefit financially in the future if this technology is commercialized.

Samir Awasthi, Nikhil Sachdeva, Yash Gupta, Ausath G Anto, Shahir Asfahan, Ruben Abbou, Sairam Bade, Sanyam Sood, Lars Hegstrom, Nirupama Vellanki, Heather M Alger, Melwin Babu, Jose R Medina-Inojosa, Robert B McCully, Amir Lerman, Mark Stampehl, Rakesh Barve, Zachi I Attia, Paul A Friedman, Venky Soundararajan, Francisco Lopez-Jimenez.
Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG.
eClinicalMedicine, 2023. doi: 10.1016/j.eclinm.2023.102259

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...